FROM THE CURRENT ISSUE: FROM THE CURRENT ISSUE: AUGUST 11, 2021; 207 (3) [Table of Contents]
There are no new Translating Immunology articles in this issue.
From Past Issues:
Translating JAKs to Jakinibs
Massimo Gadina, Danielle A. Chisolm, Rachael L. Philips, Iain B. McInness, Paul S. Changelian and John J. O’Shea
J Immunol 2020 204:
A 20-Year Journey from Axonal Injury to Neurodegenerative Diseases and the Prospect of Immunotherapy for Combating Alzheimer’s Disease
Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases
T Cell–Activating Bispecific Antibodies in Cancer Therapy
J Immunol 2019 203: 585-592
Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
J Immunol 2018 201: 1605-1613
Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies
J Immunol 2018 200: 1957-1963
Inhibitors of the PD-1 Pathway in Tumor Therapy
J Immunol 2018 200: 375-383
Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology
J Immunol 2017 198: 1381-1386
From IgE to Omalizumab
Toshiaki Kawakami and Ulrich Blank
J Immunol 2016 197: 4187-4192
Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway
Andrew B. Adams, Mandy L. Ford, and Christian P. Larsen
J Immunol 2016 197: 2045-2050
The Opportunity To Eradicate Peste des Petits Ruminants
Jeffrey C. Mariner, Bryony A. Jones, Karl M. Rich, Samuel Thevasagayam, John Anderson, Martyn Jeggo, Yi Cai, Andrew R. Peters, and Peter L. Roeder
J Immunol 2016 196: 3499-3506
G-CSF and GM-CSF in Neutropenia
Hrishikesh M. Mehta, Michael Malandra, and Seth J. Corey
J Immunol 2015 195: 1341-1349
Chimeric Antigen Receptor - and TCR-Modified T Cells Enter Main Street and Wall Street
David M. Barrett, Stephan A. Grupp, and Carl H. June
J Immunol 2015 195: 775-761
Translational Medicine in Action: Anti-CD20 Therapy in Lymphoma
Seah H. Lim and Ronald Levy
J Immunol 2014 193: 1519-1524
IL-2: The First Effective Immunotherapy for Human Cancer
Steven A. Rosenberg
J Immunol 2014 192: 5451-5458
Development and Implementation of Papillomavirus Prophylactic Vaccines
Ian H. Frazer
J Immunol 2014 192: 4007-4011
Calcineurin Inhibitors: 40 Years Later, Can't Live Without ...
Jamil R. Azzi, Mohamed H. Sayegh, and Samir G. Mallat
J Immunol 2013 191: 5785-5791
IFN-α in the Treatment of Melanoma
Ahmad A. Tarhini, Helen Gogas, and John M. Kirkwood
J Immunol 2012 189: 3789-3793
Translational Applications of Flow Cytometry in Clinical Practice
David L. Jaye, Robert A. Bray, Howard M. Gebel, Wayne A. C. Harris, and Edmund K. Waller
J Immunol 2012 188: 4715-4719
Glatiramer Acetate Treatment of Multiple Sclerosis: An Immunological Perspective
Michael K. Racke and Amy E. Lovett-Racke
J Immunol 2011 186: 1887-1890
Anti-TNF Therapy, from Rationale to Standard of Care: What Lessons Has It Taught Us?
Marc Feldmann and Ravinder N. Maini
J Immunol 2010 185: 791-794